Search Results - "Hevenor, Laura"
-
1
Discovery of First-in-Class Small Molecule Inhibitors of the IRF4-PU.1/Spi-B Interaction
Published in Blood (02-11-2023)“…Introduction Many transcription factors (TF) are promising therapeutic targets in hematological malignancies but have been mislabeled as ‘undruggable’ due to…”
Get full text
Journal Article -
2
In Situ Characterization of Chromatin Landscape in Progression of Smoldering Precursor Stage to Multiple Myeloma
Published in Blood (15-11-2022)Get full text
Journal Article -
3
Genome Sequencing to Discover Drivers of Clonal Expansion in Smoldering Multiple Myeloma
Published in Blood (02-11-2023)“…Background Better prediction models are required to identify patients with high-risk smoldering multiple myeloma (SMM) who can benefit from early intervention…”
Get full text
Journal Article -
4
Single-Cell RNA Sequencing Reveals Hypo-Responsiveness of T and NK Cells to Interferon Stimulation As an Immune Hallmark in Asymptomatic Waldenstrom's Macroglobulinemia
Published in Blood (02-11-2023)“…Introduction Waldenstrom macroglobulinemia (WM) is a rare, indolent non-Hodgkin lymphoplasmacytic lymphoma of the bone marrow (BM), characterized by monoclonal…”
Get full text
Journal Article -
5
High-Throughput Plasma Proteomics to Define the Precursor Multiple Myeloma Proteome and Identify Candidate High-Risk Disease Biomarkers of Progression
Published in Blood (02-11-2023)“…Introduction Multiple Myeloma (MM) develops from well-defined precursors Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple…”
Get full text
Journal Article -
6
Single-Cell RNA Sequencing of Circulating Tumor Cells in Precursor Myeloma Patients Reveals Mechanisms of Disease Dissemination
Published in Blood (02-11-2023)“…Introduction Multiple Myeloma (MM) is preceded by the precursors Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma…”
Get full text
Journal Article -
7
-
8
-
9
High-Throughput Plasma Proteomic Profiling to Identify Candidate High-Risk Disease Biomarkers in Precursor Multiple Myeloma Patients
Published in Blood (15-11-2022)Get full text
Journal Article -
10
Reconstructing the Genomic History of Multiple Myeloma Precursor Disease: Novel Insights and Clinical Applicability
Published in Blood (15-11-2022)Get full text
Journal Article -
11
Single-Cell RNA Sequencing of Rare Circulating Tumor Cells in Precursor Myeloma Patients Reveals Molecular Underpinnings of Tumor Cell Circulation
Published in Blood (15-11-2022)Get full text
Journal Article -
12
MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology
Published in Cancer discovery (06-02-2023)“…Multiple myeloma (MM) develops from well-defined precursor stages; however, invasive bone marrow (BM) biopsy limits screening and monitoring strategies for…”
Get more information
Journal Article -
13
-
14
-
15
-
16
-
17
Abstract 640: Genome sequencing of circulating multiple myeloma cells for minimally invasive molecular characterization of precursor disease pathology
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Introduction: Multiple myeloma (MM) develops from indolent stages monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple…”
Get full text
Journal Article -
18
Abstract 641: Single-cell RNA sequencing of rare circulating tumor cells in precursor myeloma patients reveals molecular underpinnings of tumor cell circulation
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Background: Multiple Myeloma (MM) is a hematological malignancy characterized by abnormal proliferation of terminally differentiated plasma cells…”
Get full text
Journal Article